Gjalt W. Huisman

Form D signer

Gjalt W. Huisman

Chief Executive Officer at Embold Therapeutics

Form D signer

Capital raised by Embold Therapeutics

$2.5M+$2.5M latest round

1 Form D filing · first filed Jan 2026 · Redwood City, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2023
30D INTEREST: 2 ↗

Career

1 company on file · founded 2023

Embold TherapeuticsBiotech · Redwood City, CAsince 2023

Chief Executive Officer

Signatory on Embold Therapeutics's Form D filings · $2.5M raised across 1

Company filings

via EDGAR · Form D for Embold Therapeutics1

DateCompanyFormAmountRole on filing

Jan 21, 2026Embold TherapeuticsForm D/A+$2.5MChief Executive Officer

Form D/AJan 21, 2026 · Embold Therapeutics+$2.5Mas Chief Executive Officer

Overview

Last filing Jan 21, 2026

Gjalt W. Huisman is on file as Chief Executive Officer at Embold Therapeutics in Redwood City, CA. Embold Therapeutics has 1 Form D filing on record, $2.5M raised in total. Gjalt W. Huisman appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Embold Therapeutics · 1

Gjalt HuismanDirector

Products

Embold Therapeutics · 1

EMB-0141Preclinical enzyme therapeutic

Lead preclinical program: an engineered glucocerebrosidase (GCase) variant for GBA-associated Parkinson's disease, designed to overcome the instability and poor serum half-life of natural human GCase.